You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY20 is not expected to be complete until September, 2021.

  1. Whimbrel Unmanned Aircraft System-Borne Atmospheric and Sea Surface Temperature (SST) Sensor

    SBC: Piasecki Aircraft Corporation            Topic: 845RWP

    Piasecki Aircraft (PiAC) proposes to continue development and testing efforts of the Whimbrel UAS, a low cost, expendable, air-deployed weather survey unmanned aircraft system. The Whimbrel UAS, a low cost, expendable, air-deployed weather survey unmanned aircraft system. The Whimbrel USA has been developed to support the Tropical Cyclone Boundary Layer mission requirements and contains sensors an ...

    SBIR Phase II 2015 Department of CommerceNational Oceanic and Atmospheric Administration
  2. IGF OT IGF WEB RESOURCE SYSTEM FOR PRESCRIPTION DRUG PROVIDERS RESEARCHERS AND USERS THE PRESCRIPTION DRUG ABUSE POLICY SYSTEM PDAPS POP SEPTEMBER SEPTEMBER BASE CONTRACT

    SBC: Legal Science Partners, LLC            Topic: NIDA

    Not Available

    SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health
  3. Development and Deployment of the Movable Type Method for Drug Discovery and Desi

    SBC: QuantumBio, Inc.            Topic: 300

    DESCRIPTION provided by applicant Our long term goal is to provide a solution to the protein ligand binding affinity and pose prediction problems The protein ligand docking and scoring problem is one of the central problems in computational biology because of its importance in understanding intermolecular interactions and because of its practical payoff The transformative impact molecular do ...

    SBIR Phase II 2015 Department of Health and Human Services
  4. A novel diagnostic biomarker for Hepatocellular Carcinoma(HCC)

    SBC: IMCARE BIOTECH            Topic: NCI

    DESCRIPTIONprovided by applicantHepatocellular carcinomaHCCis usually undetected until its later stageswhere theyear survival rate for patients is less thanHoweverthe survival rate can be as high asif the cancer is detected earlyUnfortunatelyearly detection of HCC is not possible with any screening tests that are currently availablesuch as ultrasound or imaging technologiesAlpha FetoproteinAFPwhic ...

    SBIR Phase II 2015 Department of Health and Human Services
  5. CATHEPSIN L INHIBITORS AS PAN CORONAVIRUS THERAPEUTICS

    SBC: PHELIX THERAPEUTICS LLC            Topic: R

    DESCRIPTION provided by applicant Coronaviruses CoV are RNA viruses that cause gastrointestinal respiratory and neurological symptoms in several mammalian species The outbreak of the severe acute respiratory syndrome CoV SARS CoV in humans was fatal in of infected patients infecting people and killing The recent incidents involving the highly pathogenic Middle East ...

    SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health
  6. TissueCypher Testing for Risk Assessment in Barretts Esophagus

    SBC: Cernostics Inc            Topic: 102

    DESCRIPTION provided by applicant Barrettandapos s esophagus is a pre neoplastic disease that predisposes patients to development of esophageal adenocarcinoma EAC Approximately million people in the US have Barrettandapos s esophagus and they are frequently screened by endoscopy with pathological analyses of esophageal biopsies The goal of the screening is to detect premalignant changes e ...

    SBIR Phase II 2015 Department of Health and Human Services
  7. Clinical Trial of ABC in Patients with Refractory Multiple Myeloma

    SBC: Apogee Biotechnology Corporation            Topic: NCI

    DESCRIPTION provided by applicant Multiple myeloma MM is the second most common hematological malignancy in the United States and remains an incurable disease since nearly all MM patients will eventually relapse and develop resistance to currently available drugs Sphingolipid metabolism is being increasingly recognized as a key pathway in tumor biology In particular sphingosine kinases S ...

    SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health
  8. Clinical Investigation of the Ceramide NanoLiposome for Advanced Solid Tumors

    SBC: KEYSTONE NANO, INC.            Topic: 102

    DESCRIPTIONprovided by applicantKeystone Nanoin partnership with the University of Maryland Greenebaum Cancer CenterUMD GCCproposes a multi site clinical evaluation of the Ceramide NanoLiposomeCNLas a novel anti cancer therapeuticThe overall objective of this project is to advance the CNL through a Phase I clinical trialThe results of this trial will support subsequent trials for the intended init ...

    SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health
  9. Multi-Modality MRI/CT Markers for Improved Assessment of Prostate Cancer

    SBC: C4 IMAGING, LLC            Topic: 102

    DESCRIPTION provided by applicant Brachytherapy radioactive seed implantation is an option for curative treatment chosen by up to of the men who develop prostate cancer in the United States each year Brachytherapy can produce excellent treatment outcomes but those outcomes vary depending on the quality of the treatment delivered which in turn depends on the positioning of th ...

    SBIR Phase II 2015 Department of Health and Human Services
  10. Preclinical Development of Tacrolimus for Radiation Cystitis

    SBC: LIPELLA PHARMACEUTICALS INC.            Topic: 400

    DESCRIPTION provided by applicant This project entitied andquot Preclinical Development of Tracrolimus for Radiation Cystitisandquot will fund key experiments to advance the commercial development of LP LP is a liposomal tacrolimus formulation for local topical intravesical administration to the urinary bladder The formulation provides active drug levels in the bladder with signific ...

    SBIR Phase II 2015 Department of Health and Human Services
US Flag An Official Website of the United States Government